Do Anxiety and Depression Predict Persistent Physical Symptoms After a Severe Covid-19 Episode? A Prospective Study
Bibliographic Data
| ID | 15527760 |
|---|---|
| Authors | Hugo Bottemanne (0000-0003-2958-0849, Institut du Cerveau, corresponding author), Clément Gouraud (0000-0002-0433-023X, Hôtel-Dieu de Paris, corresponding author), Jean‐Sébastien Hulot (0000-0001-5463-6117, Centre d'Investigation Clinique Hôpital Européen Georges Pompidou), Anne Blanchard (0000-0002-0815-0586, Assistance Publique – Hôpitaux de Paris), Brigitte Ranque (0000-0001-8549-2275, Assistance Publique – Hôpitaux de Paris), Khadija Lahlou‐Laforêt (Hôpital Européen Georges-Pompidou), Frédéric Limosin (0000-0002-0976-1514, Hôpital Corentin-Celton), Sven Günther (0000-0002-3662-1883, Université Paris Cité), David Lebeaux (0000-0002-7164-831X, Hôpital Européen), Cédric Lemogne (0000-0002-3487-4721, Institut de Psychiatrie et Neurosciences de Paris) |
| Year | 2021 |
| Volume | 12 |
| Pages | 757685-757685 |
| Publication date | 2021-11-10 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2021.757685 |
| PMID | 34858230 |
| OpenAlex | W3213384235 |
| Language | EN |
| Citations received | 3 |
| References cited | 7 |
Background: Persistent physical symptoms are common after a coronavirus disease 2019 (COVID-19) episode, but their pathophysiological mechanisms remain poorly understood. In this study, we aimed to explore the association between anxiety and depression at 1-month after acute infection and the presence of fatigue, dyspnea, and pain complaints at 3-month follow-up. Methods: We conducted a prospective study in patients previously hospitalized for COVID-19 followed up for 3 months. The Hospital Anxiety and Depression Scale (HAD-S) was administered by physicians at 1-month follow-up, and the presence of fatigue, dyspnea, and pain complaints was assessed at both 1 month and 3 months. Multivariable logistic regressions explored the association between anxiety and depression subscores and the persistence of each of the physical symptom at 3 months. Results: A total of 84 patients were included in this study (Median age: 60 years, interquartile range: 50.5-67.5 years, 23 women). We did not find any significant interaction between anxiety and the presence of fatigue, dyspnea, or pain complaints at 1 month in predicting the persistence of these symptoms at 3 months (all p ≥ 0.36). In contrast, depression significantly interacted with the presence of pain at 1 month in predicting the persistence of pain at 3 months (OR: 1.60, 95% CI: 1.02-2.51, p = 0.039), with a similar trend for dyspnea (OR: 1.51, 95% CI: 0.99-2.28, p = 0.052). Discussion and Conclusion: Contrary to anxiety, depression after an acute COVID-19 episode may be associated with and increased risk of some persistent physical symptoms, including pain and dyspnea
Anxiety · Coronavirus disease 2019 (COVID-19 · Depression (economics · Disease · Hospital Anxiety and Depression Scale · Interquartile range · Logistic regression · Persistence (discontinuity · Physical therapy · Prospective cohort study · Psychiatry · COVID-19 and Mental Health · COVID-19 Clinical Research Studies · Long-Term Effects of COVID-19 · Medicine · Internal Medicine
Association between use of psychotropic medications prior to Sars-COV-2 infection and trajectories of Covid-19 recovery
Comparative study of quality of life 9 months post-Covid-19 infection with Sars-CoV-2 of varying degrees of severity
Psychometric Properties of the Hospital Anxiety and Depression Scale (Hads) in Previously Hospitalized Covid-19 Patients
How mental health care should change as a consequence of the Covid-19 pandemic
Anxiety and depression in Covid-19 survivors
Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (Sars)
Post-acute Covid-19 syndrome
Are we facing a crashing wave of neuropsychiatric sequelae of Covid-19? Neuropsychiatric symptoms and potential immunologic mechanisms
Development and Validation of the Somatic Symptom Disorder–B Criteria Scale (SSD-12)
Association Between Psychological Distress, Cognitive Complaints, and Neuropsychological Status After a Severe Covid-19 Episode
| Unique citing works | 3 |
|---|---|
| Citations per year | 0.75 |
| Citation span | 2022 - 2023 (2) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 3 |